1230.2.23 Boehringer Ingelheim Investigational Site

New York, New York

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms

Studies at this site

• Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer — Completed